Prediction and Prevention of Ovarian Hyperstimulation Syndrome
- Author:
Hye Ok KIM
1
;
Inn Soo KANG
Author Information
1. Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Kwandong University School of Medicine, Seoul, Korea. ikang67@yahoo.co.kr
- Publication Type:Review
- Keywords:
OHSS;
Risk factors;
Prevention;
Metformin;
Dopamine agonist
- MeSH:
Cryopreservation;
Dopamine Agonists;
Embryonic Structures;
Female;
Gonadotropin-Releasing Hormone;
Gonadotropins;
Humans;
Metformin;
Ovarian Hyperstimulation Syndrome;
Ovulation;
Ovulation Induction;
Risk Factors
- From:Korean Journal of Fertility and Sterility
2010;37(4):293-305
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Ovarian hyperstimulation syndrome (OHSS) is a life-threatening iatrogenic complication of ovulation induction. Before ovarian stimulation, identification of patients vulnerable to developing OHSS is necessary. And ovarian stimulation should be started with low doses of gonadotropin or GnRH antagonist protocol. During monitoring of ovarian stimulation with risk of OHSS, coasting, low doses hCG and GnRH agonist for triggering ovulation are considered. If severe OHSS is predicted, cycle cancellation and cryopreservation of all embryos should be considered to reduce late-onset OHSS and morbidity. And metformin and dopamine agonist for reducing OHSS are being proposed as a prophylactic treatment for OHSS.
